Since an increased expression and FGFR4 in the tumor tissues predicts a poor prognosis in various cancers and its targeting has proven promising in the treatment of FGFR4-mediated tumors, understanding molecular mechanisms that regulate FGFR4 expression in GC might be of therapeutic relevance. This evidence concerns the gene FGFR4 and neoplasm.